Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically 
relevate behavioral and neuroendocrine effects of chronic paroxetine treatment 
in a psychopathological rat model

Keck, Martin E.; Welt, Tobias; Müller, Marianne B.; Uhr, Manfred; Ohl, Frauke; Wigger, Alexandra; Toschi, Nicola; Holsboer, Florian; Landgraf, Rainer

Lokale TagsFreigabegeschichteDetailsÜbersicht

Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model

Keck, M. E., Welt, T., Müller, M. B., Uhr, M., Ohl, F., Wigger, A., et al. (2003). Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology, 28(2), 235-243.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-9F45-4 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-9F46-2

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Keck, Martin E., Autor
Welt, Tobias, Autor
Müller, Marianne B.¹, Autor
Uhr, Manfred², Autor
Ohl, Frauke³, Autor
Wigger, Alexandra, Autor
Toschi, Nicola⁴, Autor
Holsboer, Florian⁵, Autor
Landgraf, Rainer⁴, Autor

Affiliations:
1AG Müller, Marianne, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607153
2AG Uhr, Manfred, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607163
3Max Planck Institute of Psychiatry, Max Planck Society, ou_1607137
4AG Landgraf, Rainer, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607151
5Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607139